Drawing for RECURSION PHARMACEUTICALS

USPTO serial 87356066

RECURSION PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 5310306Status 710
Filing date
Status date
Registration date
Oct 17, 2017
Examiner
GRIFFIN, JAMES
Law office
TMEG LAW OFFICE 103

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with RECURSION PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David P. Johnson

David P. Johnson WORKMAN NYDEGGER60 E SOUTH TEMPLESUITE 1000SALT LAKE CITY, UT 84111

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery servicesSECTION 8 - CANCELLEDNov 16, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 3, 2024C8..CANCELLED SEC. 8 (6-YR)—
Oct 17, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 16, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Mar 12, 2021EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Feb 26, 2021PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Feb 16, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 21, 2021ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 17, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 1, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 7, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jun 7, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 7, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 7, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 27, 2017GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 27, 2017GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 27, 2017CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 25, 2017DOCKASSIGNED TO EXAMINER—
Mar 10, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 6, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance